GlassScriptPhysician profile
Mohammad M Marashdeh
NPI 1689860819
$1,142.69
in general payments reported to CMS, 2019-2025
16 companies · $165 in 2025
The $165 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2020: $36.85 · 2022: $310 · 2023: $334 · 2024: $149 · 2025: $165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $649.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $648.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $233.20 | 2020-2025 | |
| Boston Scientific Corporation | $145.59 | 2020-2022 | |
| Amgen INC. | $132.79 | 2022-2025 | Repatha |
| Edwards Lifesciences Corporation | $132.15 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| E.R. Squibb & Sons, L.L.C. | $86.00 | 2019-2024 | Camzyos |
| Novartis Pharmaceuticals Corporation | $74.61 | 2019-2023 | |
| Heartflow, INC. | $69.50 | 2025 | |
| Novo Nordisk INC | $59.92 | 2023-2025 | Wegovy, Ozempic |
| Astrazeneca Pharmaceuticals LP | $51.23 | 2020-2022 | |
| Regeneron Healthcare Solutions, INC. | $30.83 | 2019 | |
| Alnylam Pharmaceuticals INC. | $27.56 | 2023 | Onpattro |
| Sanofi-Aventis U.S. LLC | $26.77 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $20.05 | 2019 | |
| Cardiva Medical, INC. | $19.45 | 2022 | |
| Abbott Laboratories | $18.75 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.29 | 2024 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Marashdeh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.